N/A
Completed N=6,125
Lung Cancer Screening Eligibility Assessment
Source: ClinicalTrials.gov NCT06133816 ↗Enrolled (actual)
6,125
Serious AEs
0.0%
Results posted
May 2025
Primary outcomePrimary: Full Survey Completion — 358; 381; 383; 389 Participants
Summary
The primary purpose of this study evaluate if different messaging impacts response rates to a brief survey (i.e., the simplified eligibility tool) that is designed to estimate pack-year eligibility for lung cancer screening (LCS). This will help inform the best way to increase response rates to the tool in future intervention studies designed to increase LCS, and expand upon survey methodology in general.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Full Survey Completion |
358; 381; 383; 389; 372; 399 | — |
| SECONDARY Partial Survey Completion |
377; 405; 394; 403; 381; 414 | — |
Eligibility Criteria
Inclusion Criteria
- meet age eligibility (50-80 years old) for LCS based on 2021 USPSTF guidelines; and
- have completed at least one primary care visit at Penn Medicine in 2020-2025
Exclusion Criteria
- have a documented history of lung cancer;
- have a documented history of completing LCS at Penn Medicine;
- are listed as not wanting to be contacted or solicited for research; or
- do not otherwise meet inclusion criteria.
Data sourced from ClinicalTrials.gov (NCT06133816). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.